Skip to content

Venture capital

Page 13







Has the successful IPO of a fast-food giant made the ASX more digestible for Australia's tech startups? Investors say yes, while founders are more cautious.






A loss by Tesla chair Robyn Denholm's Wollemi Capital Group in a trademark dispute with Tim Bishop's climate tech VC firm isn't necessarily a setback for other related disputes.


The case of Adir Shiffman v Sleeping Duck offers a rare insight into the tactics of those angels who typically invest alone and in a very different way to conventional VCs.







Apparently Apple just sherlocked a whole bunch of startups with its AI announcement. Or maybe the bar for what makes an AI startup investible just got a little higher?








The Aussie tech giant has invested in Figma after Adobe's failed bid to buy the company. Between Figma and Canva, design tech is flourishing — which is great news for Mike Cannon-Brookes.



The Australian government has banned the sale of compounded Ozempic. VC-backed Eucalyptus, which will be hit by the decision, says the government is cutting off supply to those who rely on it.






Plans to tax unrealised gains on earnings from superannuation accounts over $3 million are another potential hit to a startup ecosystem still reeling from proposals to lift sophisticated investor thresholds.






What if the $1 billion PsiQuantum deal had less to do with supporting innovation and more to do with national security?




At Australia's biggest startup festival there was widespread optimism that a tough period for the ecosystem is finally coming to an end.


Next page